vs
Side-by-side financial comparison of Dominari Holdings Inc. (DOMH) and Electromed, Inc. (ELMD). Click either name above to swap in a different company.
Dominari Holdings Inc. is the larger business by last-quarter revenue ($30.1M vs $18.9M, roughly 1.6× Electromed, Inc.). Electromed, Inc. runs the higher net margin — 14.6% vs -438.1%, a 452.7% gap on every dollar of revenue. On growth, Dominari Holdings Inc. posted the faster year-over-year revenue change (220.4% vs 16.3%). Over the past eight quarters, Dominari Holdings Inc.'s revenue compounded faster (369.1% CAGR vs 16.7%).
Electromed, Inc. is a specialized medical device firm developing, manufacturing, and distributing advanced respiratory care products. Its core offerings are high-frequency chest wall oscillation systems that clear airway secretions for patients with cystic fibrosis, COPD and other respiratory conditions, serving U.S. home care and clinical customers.
DOMH vs ELMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $30.1M | $18.9M |
| Net Profit | $-131.8M | $2.8M |
| Gross Margin | — | 78.4% |
| Operating Margin | -8.9% | 19.2% |
| Net Margin | -438.1% | 14.6% |
| Revenue YoY | 220.4% | 16.3% |
| Net Profit YoY | -12426.2% | 40.3% |
| EPS (diluted) | $-6.94 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $30.1M | $18.9M | ||
| Q3 25 | $50.8M | $16.9M | ||
| Q2 25 | $34.1M | $17.4M | ||
| Q1 25 | $8.1M | $15.7M | ||
| Q4 24 | $9.4M | $16.3M | ||
| Q3 24 | $4.0M | $14.7M | ||
| Q2 24 | $6.2M | $14.8M | ||
| Q1 24 | $1.4M | $13.9M |
| Q4 25 | $-131.8M | $2.8M | ||
| Q3 25 | $125.2M | $2.1M | ||
| Q2 25 | $16.6M | $2.2M | ||
| Q1 25 | $-32.5M | $1.9M | ||
| Q4 24 | $1.1M | $2.0M | ||
| Q3 24 | $-4.2M | $1.5M | ||
| Q2 24 | $-6.1M | $1.8M | ||
| Q1 24 | $-5.4M | $1.5M |
| Q4 25 | — | 78.4% | ||
| Q3 25 | — | 78.1% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 78.0% | ||
| Q4 24 | — | 77.7% | ||
| Q3 24 | — | 78.3% | ||
| Q2 24 | — | 76.2% | ||
| Q1 24 | — | 74.8% |
| Q4 25 | -8.9% | 19.2% | ||
| Q3 25 | -3.1% | 15.8% | ||
| Q2 25 | -57.0% | 17.5% | ||
| Q1 25 | -394.6% | 13.6% | ||
| Q4 24 | 0.4% | 15.6% | ||
| Q3 24 | -79.1% | 13.2% | ||
| Q2 24 | -44.3% | 15.7% | ||
| Q1 24 | -205.2% | 13.3% |
| Q4 25 | -438.1% | 14.6% | ||
| Q3 25 | 246.4% | 12.6% | ||
| Q2 25 | 48.7% | 12.7% | ||
| Q1 25 | -400.5% | 12.1% | ||
| Q4 24 | 11.4% | 12.1% | ||
| Q3 24 | -104.2% | 10.0% | ||
| Q2 24 | -99.1% | 12.3% | ||
| Q1 24 | -398.0% | 10.8% |
| Q4 25 | $-6.94 | $0.32 | ||
| Q3 25 | $7.27 | $0.25 | ||
| Q2 25 | $1.12 | $0.26 | ||
| Q1 25 | $-3.02 | $0.21 | ||
| Q4 24 | $0.21 | $0.22 | ||
| Q3 24 | $-0.67 | $0.16 | ||
| Q2 24 | $-1.01 | $0.20 | ||
| Q1 24 | $-0.91 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.5M | $13.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $69.4M | $45.4M |
| Total Assets | $112.9M | $54.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.5M | $13.8M | ||
| Q3 25 | $176.2M | $14.1M | ||
| Q2 25 | $28.2M | $15.3M | ||
| Q1 25 | $18.9M | $15.2M | ||
| Q4 24 | $8.2M | $16.2M | ||
| Q3 24 | $7.2M | $13.9M | ||
| Q2 24 | $12.1M | $16.1M | ||
| Q1 24 | $7.1M | $11.7M |
| Q4 25 | $69.4M | $45.4M | ||
| Q3 25 | $210.2M | $44.7M | ||
| Q2 25 | $88.6M | $43.2M | ||
| Q1 25 | $42.4M | $43.9M | ||
| Q4 24 | $39.9M | $43.6M | ||
| Q3 24 | $38.3M | $41.5M | ||
| Q2 24 | $42.4M | $44.5M | ||
| Q1 24 | $47.7M | $42.5M |
| Q4 25 | $112.9M | $54.9M | ||
| Q3 25 | $223.4M | $53.6M | ||
| Q2 25 | $109.3M | $53.8M | ||
| Q1 25 | $52.3M | $52.5M | ||
| Q4 24 | $47.1M | $52.3M | ||
| Q3 24 | $43.4M | $48.9M | ||
| Q2 24 | $49.1M | $52.2M | ||
| Q1 24 | $52.2M | $48.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $22.7M | $3.0M |
| Free Cash FlowOCF − Capex | — | $2.4M |
| FCF MarginFCF / Revenue | — | 12.7% |
| Capex IntensityCapex / Revenue | — | 3.4% |
| Cash ConversionOCF / Net Profit | — | 1.10× |
| TTM Free Cash FlowTrailing 4 quarters | — | $7.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.7M | $3.0M | ||
| Q3 25 | $-4.9M | $169.0K | ||
| Q2 25 | $-353.0K | $3.9M | ||
| Q1 25 | $1.2M | $2.1M | ||
| Q4 24 | $-16.7M | $3.2M | ||
| Q3 24 | $-4.7M | $2.3M | ||
| Q2 24 | $1.4M | $4.5M | ||
| Q1 24 | $-8.6M | $1.4M |
| Q4 25 | — | $2.4M | ||
| Q3 25 | — | $-83.0K | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $1.9M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $2.3M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | — | $1.3M |
| Q4 25 | — | 12.7% | ||
| Q3 25 | — | -0.5% | ||
| Q2 25 | — | 21.4% | ||
| Q1 25 | — | 12.2% | ||
| Q4 24 | — | 18.0% | ||
| Q3 24 | — | 15.5% | ||
| Q2 24 | — | 30.1% | ||
| Q1 24 | — | 9.1% |
| Q4 25 | — | 3.4% | ||
| Q3 25 | — | 1.5% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | 1.4% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 0.6% |
| Q4 25 | — | 1.10× | ||
| Q3 25 | -0.04× | 0.08× | ||
| Q2 25 | -0.02× | 1.75× | ||
| Q1 25 | — | 1.10× | ||
| Q4 24 | -15.65× | 1.60× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | — | 2.46× | ||
| Q1 24 | — | 0.90× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
ELMD
| Homecare | $17.3M | 91% |
| Other | $1.6M | 9% |
